This Drug Could be the Most Crucial in Regeneron's Massive Pipeline Post author:Sam Post published:August 22, 2017 Post category:BioPharma August 23, 2017By Mark Terry, BioSpace.com Breaking News… Source: BioSpace You Might Also Like Amgen's Repatha Reduces Cardiovascular Events in Patients with a History of Heart Attacks November 14, 2017 It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash January 25, 2017 ProMetic Life Sci Reports Its 2016 Fourth Quarter And Year End Highlights And Financial Results March 30, 2017
Amgen's Repatha Reduces Cardiovascular Events in Patients with a History of Heart Attacks November 14, 2017
It's Finally Happening: Johnson & Johnson Pays $30 Billion for Actelion, Will Spin Off R&D Unit With $1 Billion Cash January 25, 2017
ProMetic Life Sci Reports Its 2016 Fourth Quarter And Year End Highlights And Financial Results March 30, 2017
